Delivery Order SPE2DB24D3014-SPE2DB25FKUPG
Award Date 9/4/25
Potential Completion Date 9/5/25
Potential Value $9.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,783.60 on May 13, 2025, for the supply of Vyvanse 40 mg capsules (100-count units) by the Defense Logistics Agency. This contract utilizes firm fixed pricing under a non-set-aside, competitively awarded arrangement with an ultimate completion date of May 14, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $6,108.12 delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Vyvanse 10 mg capsules (100-count units). This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Vyvanse 60 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $1,946.30. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by April 25, 2025. This delivery order represents a continuation of AmerisourceBergen's role as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 29, 2025, for the supply of Vyvanse 60 mg capsules (100-count units). The contract was competitively awarded without set-aside designation and carries a ceiling value of $1,065.93, with a firm fixed price structure and an ultimate completion date of September 2, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,884.22 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by August 18, 2025, with fulfillment from the contractor's corporate office located in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,376.94 by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025, for the supply of Vyvanse 60 mg capsules. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of September 17, 2025, and will be performed at the company's Conshohocken facility. The...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a contract value of $2,279.71 and a firm fixed price structure. The order is set to be completed by August 27, 2025, with fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $12,936 firm fixed price delivery order for Vyvanse Caps 30mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 6, 2025, for Vyvanse 40 mg capsules (100-count units) valued at $4,250.18. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 7, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Vyvanse 20 mg capsules (100 count) valued at $3,086.82. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is issued...